Appointments at inVentiv, AMRI, ShangPharma and ERT – People on the move

By Nick Taylor

- Last updated on GMT

Related tags Chief financial officer Chief operating officer Management occupations

Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at inVentiv, AMRI, ShangPharma and ERT.

inVentiv Health​ has hired Rick Finnegan​ as executive vice president (EVP) of international business in its commercial services division. Finnegan has previously worked at Glenmark Therapeutics and Merck & Co.

Bruce Sargent​ has been promoted to SVP, drug discovery at AMRI​. Sargent joined AMRI in 2001 and will now lead its newly created global drug discovery organisation.

ShangPharma​ has appointed William Dai​ as chief financial officer (CFO). Dai last worked at China Nepstar Chain Drugstore. Kevin Penghui Chen​, the former CFO, will become president while continuing as chief operating officer (COO).

Tracy Burr​ has joined PharmaZell​ as chief technology officer and has taken charge of all research and development activities.

Camargo Pharmaceutical Services​ has hired Ray Dawkins​ as chief medical officer. Dawkins has previously worked at Paragon Biomedical and Talecris Biotherapeutics.

Shawn Cavanagh ​has been named EVP and COO at Cambrex​. Cavanagh worked at Cambrex Bioproducts when it was acquired by Lonza in 2007. Since then Cavangh has worked at Lonza but has now rejoined Cambrex to oversee contract manufacturing.

ERT​ has elected Joel Morganroth​ as interim-CEO and president after Michael McKelvey​ retired from the positions. Morganroth has been involved with ERT since 1977 and most recently worked as chairman and chief scientific officer.

Richard Rosenbloom​ has been appointed to the medical advisory panel at ClinACE​.

Ampac Fine Chemicals ​president Aslam Malik​ has joined the Society of Chemical Manufacturers and Affiliates ​(SOCMA​) board of directors. Malik has been president of Ampac Fine Chemicals since 2005 and has 24 years of industrial experience in fine chemical scale-up.

Related topics Markets & Regulations

Related news

Show more

Follow us


View more